DENSO to Exhibit at “Automechanika Dubai 2024” JCN Newswire

DENSO to Exhibit at “Automechanika Dubai 2024”

KARIYA, JAPAN, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - DENSO Sales Middle East & North Africa (DSMN), a group company of DENSO Corporation, will participate in “Automechanika Dubai 2024,” held at the Dubai World Trade Centre from December 10 to 12, 2024.Established in 2010 in Dubai, DSMN serves the Middle East and North Africa regions by offering aftermarket products and services. In these regions, motorization is advancing, and vehicles tend to have longer operational lifespans. DSMN strives to provide customers and users with peace of mind and trust through high-quality products and services, contributing to the realization of a sustainable mobility society.Automechanika Dubai is the largest automotive aftermarket trade show in the Middle East and Africa. This year, over 2,200 exhibitors are expected to participate. Many visitors are businesses seeking to establish partnerships with exhibitors, and attendance is anticipated to exceed last year’s 52,469 visitors from 161 countries. The event offers an excellent opportunity to expand business possibilities, not only in the Middle East and Africa but also in regions such as West Asia and Central Asia.Through this exhibition, DSMN aims to showcase aftermarket solutions and explore opportunities for advanced technology-based products and services. Additionally, DSMN will deepen interactions with customers and partner companies, identifying new needs and pursuing tailored solutions to address regional challenges.Booth ImageDSMN Website: https://denso.ae/Please see here for more details on DSMN’s booth: https://denso.ae/events/join-us-at-automechanika-dubai-2024-celebrating-75-years-of-innovation Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Fujitsu expands global strategic collaboration agreement with AWS to promote customer digital transformation across industries JCN Newswire

Fujitsu expands global strategic collaboration agreement with AWS to promote customer digital transformation across industries

KAWASAKI, Japan, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has signed a three-year global strategic collaboration agreement (SCA) with Amazon Web Services (AWS) (1). This collaboration, officially concluded on November 29, expands the existing agreements in the mobility, finance, and retail sectors to a broader range of industries .Through this collaboration, Fujitsu will combine its expertise in systems integration and its Fujitsu Uvance offering to solve societal issues with AWS’s cloud services and cloud-native architecture to accelerate customers' digital transformation (DX) and address business challenges.Additionally, with AWS’s skills training, Fujitsu aims to strengthen its delivery system by increasing the number of Fujitsu engineers who have AWS certifications from approximately 7,000 to 12,000 over the next three years and double the number of customer deals to over 800 compared to the past 3-year SCA period.BackgroundWith the target year of 2030 for achieving the United Nations Sustainable Development Goals (SDGs) approaching, Fujitsu is promoting Fujitsu Uvance, its business model that aims to increase business growth and solve societal issues.Fujitsu Uvance leverages Fujitsu's extensive technology and industry expertise to seamlessly integrate fragmented processes and data, with the aim of creating new solutions and insights for customers. To achieve this, it is crucial to move away from legacy systems and strategically utilize cloud computing with partners. By expanding strategic collaboration with AWS, the world’s most comprehensive and broadly adopted cloud, and creating a combined solution that address customers business challenges and opportunities, Fujitsu will drive digital transformation across industries.Overview of the Initiatives1. Strengthening Fujitsu’s AWS cloud migration support servicesIn addition to having customers core systems run on their mainframes and UNIX servers, which was a strategic target of the legacy modernization collaboration announced in March 2024, the two companies will strengthen migration support services for broader on-premise systems to move onto AWS. Fujitsu will provide a comprehensive set of cloud-native system integration and operation support services through Fujitsu Cloud Transformation Service and Fujitsu Cloud Managed Service (2), with technical support from AWS.2. Enhancing added value through the service integration of Fujitsu Uvance offerings and AWSFujitsu aims to enhance added value and expand the global provision of Fujitsu Uvance offerings focusing on the two pillars of Trusted Society for a prosperous and sustainable society and Digital Shifts to support customers' data-driven strategies. As part of this effort, Fujitsu has started linking the Digital Shifts offering with its Fujitsu Kozuchi AI service and Amazon Bedrock, AWS's generative AI service. For example, Fujitsu Data Intelligence Premium, an operation platform that utilizes data and AI, analyzes production line data from factories, uses AI to detect risk signs and propose countermeasures based on past cases, and converts past inspection reports into reusable structured data to visualize and share accumulated know-how in facility maintenance work within organizations. By combining business knowledge cultivated over many years with the latest technologies such as generative AI, Fujitsu will help customers improve the efficiency and the uptime of their production processes. Demonstrations of these use cases will be showcased at the Fujitsu booth during AWS re:Invent 2024 starting today in Las Vegas, US.(3)3. Reinforcing Fujitsu’s system development and delivery capabilities by increasing the number of AWS certification holdersFujitsu aims to increase the number of Fujitsu engineers who hold AWS certifications from approximately 7,000 to 12,000 over the next three years, through AWS skills training. By increasing the number of professionals who have a deep understanding of AWS cloud services, Fujitsu will accelerate the delivery of systems that realize customers' DX, doubling the number of customer deals to over 800 compared to past 3-year SCA period.Role of Fujitsu and AWS- FujitsuLeverage its customer base and system development expertise in various industries to reach enterprise and mid-market customers.Through offerings such as legacy system modernization, cloud migration and operational support, and Fujitsu Uvance, Fujitsu will support customers' DX.- AWSAWS will strengthen its technical support for Fujitsu with its solution architects and provide advisories on the use of latest AWS services such as generative AI and cloud-native architectures for diverse use cases. AWS will also provide development environments to review latest AWS services, while also offering funds for joint sales and marketing, and AWS training and certifications for Fujitsu engineers.Yoshinami Takahashi, Vice President and COO for Uvance, Fujitsu Limited comments:“We are pleased to have concluded this global strategic collaboration with AWS. By extending our strategic collaboration to a broader range of industries, we will contribute to the digital transformation of customers across industries through legacy modernization, cloud lift and shift, and the utilization of technology and data offerings from Fujitsu Uvance together with AWS."Jaime Vallés, Vice President, Asia Pacific and Japan, Amazon Web Services comments:"Since 2012, AWS and Fujitsu have supported the digital transformation of customers in the mobility, finance, and retail sectors in Japan and worldwide. Today, we are delighted to expand our strategic collaboration with Fujitsu. Together we will broaden our Digital Transformation Experience to enable a wider range of industries and leverage our shared culture of innovation to jointly address some of the world’s biggest challenges."(1) Amazon Web Services: Headquartered in Seattle, Washington, USA, CEO Matt Garman. The collaboration was concluded with Amazon Web Services Japan GK (Head Office: Shinagawa-ku, Tokyo; President: Akihiko Shirahata).(2) Fujitsu Cloud Transformation Service and Fujitsu Cloud Managed Service: Based on Fujitsu's system design, construction, and operation know-how cultivated mainly in the enterprise domain, these services realize standardization and automation of architecture patterns, ensuring high quality while achieving cost-optimized and rapid delivery. Fujitsu adopts the "AWS Well-Architected Framework" in its delivery services, which is optimized for AWS, and has obtained the "AWS Managed Service Provider (MSP)" certification, proving the soundness and high technical capability of its AWS business.(3) AWS re:Invent: AWS’s annual global conference that starts from December 2, 2024 in Las Vegas. For more information on AWS re:Invent, please visit: https://reinvent.awsevents.com/About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.
More
MeAI Sees Strong Support from Top Launchpad CEOs Following Sold-Out IDO SeaPRwire

MeAI Sees Strong Support from Top Launchpad CEOs Following Sold-Out IDO

New York, NY – December 02, 2024 – (SeaPRwire) – MeAI, a leading innovator in AI and DeSci, announces the listing of its native token, $MEAI, following a successful Initial Dex Offering (IDO). The first AI-powered Web3 lifestyle app that integrates GameFi, SocialFi, and DeSci has successfully completed its IDO, achieving record sell-outs on 6 major launchpads (Enjinstarter, Spores, Dappad, BullPerks, BRC Starter, and Vision Launch). MeAI is set to launch on the BNB chain, and recently announced the $MEAI listing on MEXC, a top tier CEX. Key Achievements: Sold-out IDO: $MEAI IDO sell-outs in record time raising over $650,000 Expansive Network: Over 60 top-tier web3 and AI partnerships Strong support: Over 100 Private and Angel Investors Strong foundations: 435,000+ followers across socials Active community: 250,000+ active users in the MeAI Mini-app 5-star rating: MeAI Mini is ranked in the Top 5 Telegram Mini Apps by BNB Chain’s DappBay The rapid success behind the completion of the MeAI IDO and token listing positions MeAI as an emerging leader in the AI and DeSci sector. Backed by industry leaders In a recent AMA hosted by MeAI, numerous launchpad CEOs came together to discuss the $MEAI IDO and their views on the project outlook. The panel unanimously agreed that MeAI is well-positioned for success, and effectively capitalizes on the rising trends in DeSci and AI in order to become a key player in the rapidly growing market. Eran Elhanani, CEO of BullPerks, a top decentralized VC and multichain launchpad, signalled his confidence in the project, highlighting the rapid sold-out performance on BullPerks as a testament to MeAI’s strong potential and long-term viability. Market demand and investor confidence was clearly present. Mustafa Guler, CEO of Vision Launch, shared his view that MeAI was ‘one to watch’ describing it as a project with immense potential. With innovative approaches and solid foundations, MeAI was described as being poised for significant growth, with traction and momentum clearly growing behind the project. A Strong vision is set MeAI has outlined its ambitious plans for the future, detailing clear goals for scaling the project. Key to its strategy will be expanding into new markets and integrating with major blockchains, both of which are essential for driving mass adoption and growing its user base. The development and release of the main MeAI app for iOS and Android is coming soon, with an MVP launch set for Q1 2025. The team has set a target of 100k+ users for the MVP and 1M users by the end of 2025. The full MeAI app, which will feature all four modules, is expected to be completed by the end of 2025. About MeAI MeAI is the first AI-powered Web3 lifestyle app that combines fun with GameFi, SocialFi, and DeSci, to enhance both your health and wealth. Turn daily routines into exciting challenges with your unique avatar, and immerse yourself in a gamified experience. Progress through quests, achieve milestones, and level up your in-app character to earn rewards through MeAI’s integrated rewards model. MeDiet – Snap pictures of your meals, let AI analyze your plate, stay healthy, and earn rewards. MeExplore – Explore the world, complete quests solo or in teams, stay active, and get rewarded. MeSocial – Connect with other players, share experiences, challenge friends, socialize, and grow together. MeGrowth – Develop yourself, expand your career, and let AI guide you towards a better life. White Paper https://meai.gitbook.io/meai-litepaper Trade $MEAI https://www.mexc.com/exchange/MEAI_USDT Social Links X: https://x.com/meai_app Discord: https://discord.com/invite/meai-903228536867946568 Telegram: https://t.me/meai_app LinkedIn: https://www.linkedin.com/company/meai-app/ YouTube: https://www.youtube.com/@meai_app Instagram: https://www.instagram.com/meai_app/ Medium: https://medium.com/@meai_app Media contact Brand: MeAI Contact: Media team Email: support@meai.app Website: https://www.meai.app/ The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...
More
云顶新耀宣布中国香港卫生署正式受理伊曲莫德(VELSIPITY(R)) ACN Newswire

云顶新耀宣布中国香港卫生署正式受理伊曲莫德(VELSIPITY(R))

上海, 2024年12月2日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀(HKEX 1952.HK)是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司,今日宣布中国香港卫生署已正式受理伊曲莫德(VELSIPITY(R))用于治疗中重度活动性溃疡性结肠炎成人患者的新药上市许可申请(NDA)。伊曲莫德是一款每日一次口服的一线先进疗法,不仅使用方便、疗效佳,而且具有良好的安全性特征。伊曲莫德已于去年10月和今年2月先后在美国和欧盟获得新药上市批准,同时,伊曲莫德也于今年4月获得中国澳门特别行政区药物监督管理局批准上市,并于今年10月通过"港澳药械通"政策在粤港澳大湾区落地。云顶新耀首席执行官罗永庆表示:"我们非常高兴看到伊曲莫德的新药上市许可申请在中国香港获得正式受理。自身免疫性疾病是我们的重点关注领域和重要价值的潜在增长动力。到2030年,中国的溃疡性结肠炎患者人数预计将达到约100万人,超过2019年患者人数的一倍以上,存在迫切且巨大的未被满足的临床需求。伊曲莫德已在中国澳门获批,并通过"港澳药械通"政策率先在粤港澳大湾区落地。今年我们预计也将在中国大陆地区递交伊曲莫德的新药上市许可申请。期待伊曲莫德在更多地区获批,进一步扩大可及性,造福广大患者。"伊曲莫德亚太临床试验牵头研究者、世界胃肠病学会执行理事、亚太消化学会副主席、中国人民解放军空军军医大学附属西京医院吴开春教授表示:"祝贺伊曲莫德取得的这一新进展,为中国香港的患者带来了希望。伊曲莫德具有良好的获益-风险特征,这种新一代S1P受体调节剂通过每日一次口服的治疗方案,可快速起效,并达到无激素缓解、黏膜愈合,可为中重度活动性溃疡性结肠炎成人患者提供先进的治疗选择。我们期待伊曲莫德在大中华区及其他亚洲国家早日获批,为患者带来福音。"伊曲莫德的申请是基于ELEVATE UC III期注册研究(ELEVATE UC 52和ELEVATE UC 12)的结果,该研究旨在评价既往对至少一种常规治疗、生物制剂或Janus激酶(JAK)抑制剂治疗失败或不耐受的中重度活动性溃疡性结肠炎患者,每日一次服用2mg 伊曲莫德的安全性和疗效。在ELEVATE UC 52和ELEVATE UC 12中,纳入了一半以上严重活动性溃疡性结肠炎患者(mMS≥7),并有近三分之一患者曾接受过生物制剂或JAK抑制剂治疗。伊曲莫德的UC研究也是迄今唯一纳入了孤立性直肠炎患者的UC研究。这两项随机、双盲、安慰剂对照研究均达到了所有主要和关键次要终点,安全性特征与既往研究一致。在ELEVATE UC 52研究中,第12周时,接受伊曲莫德治疗的患者临床缓解率为27.0%(安慰剂组7.0%, 差异20.0%,P
More
MHI Receives Order from Taiwan High Speed Rail Corporation for Trackwork and Core System for New Rolling Stock Inspection Shop in Zuoying Depot JCN Newswire

MHI Receives Order from Taiwan High Speed Rail Corporation for Trackwork and Core System for New Rolling Stock Inspection Shop in Zuoying Depot

TOKYO, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) has received an order from Taiwan High Speed Rail Corporation to install new equipment and modify existing equipment for the expansion of the existing maintenance shop at Taiwan High Speed Rail's (THSR) Zuoying depot in southern Taiwan. MHI will design, supply and install trackwork, overhead catenary system, power supply system, and signaling system.THSR plays a key role in Taiwan's transportation infrastructure. Its annual ridership has increased from around 15 million passengers during its inaugural year in 2007, to nearly 73 million in 2023, with the cumulative ridership to date now exceeding 800 million. To better serve this increasing demand, THSR is boosting its capacity by adding 12-car train sets and expanding the associated inspection and maintenance facilities which MHI will undertake. These upgrades will enable an increase in train car operations, which will further enhance transportation convenience across Taiwan and support its economic growth.The THSR project was initially awarded to a consortium of seven Japanese companies, including MHI, in 2000. Operations were inaugurated in January 2007. MHI's involvement continued with the Nangang Extension Project(Note) and subsequent system upgrade work, and the latest contract was awarded to MHI in recognition of these and other ongoing contributions to THSR's development.Going forward, MHI will continue contributing to the THSR's development through its expertise in transportation systems and project management capabilities, further enhancing Taiwan's transportation infrastructure.For details concerning the Nangang Extension Project, refer to the following news release: www.mhi.com/news/130624en.htmlAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.
More
ULVAC Launches New Deposition System for Semiconductor Applications: Model “ENTRON-EXX” JCN Newswire

ULVAC Launches New Deposition System for Semiconductor Applications: Model “ENTRON-EXX”

Chigasaki, Japan, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - ULVAC, Inc. (HQ: Chigasaki, Kanagawa) has started accepting orders for the ENTRON-EXX, a new multi-chamber deposition system for semiconductor applications. The ENTRON-EXX builds on the proven productivity and flexibility of its predecessor, the ENTRON-EX W300, while offering enhanced data intelligence and expandability.After building on the proven productivity and flexibility of the widely adopted predecessor model that was first released in 2005, we developed the ENTRON-EXX. The ENTRON-EXX is a cutting-edge platform designed to meet the evolving needs of increasingly advanced and complex semiconductor manufacturing processes. This next-generation system takes performance to new heights. With its flexibility, enhanced data collection and analysis capabilities and a highly scalable design, the ENTRON-EXX empowers the future of semiconductor innovation.Key Features of ENTRON-EXX:1. Maximizing Factory Space Efficiency:Maximizing factory space efficiency is the key to boosting productivity, and flexibility is the solution. The ENTRON-EXX offers two versatile platform options, Single and Tandem[1], enabling customers to select the best platform to fit their factory spaces, thereby achieving maximum productivity per unit of space.2. Enhanced Data Collection and Analysis Capabilities:To meet the demands of increasingly complex semiconductor manufacturing, the ENTRON-EXX significantly enhances its data collection and analysis capabilities. With real-time processing of large data volumes, it empowers customers to improve yields, optimize preventative maintenance, and enhance overall operational efficiency.3. Highly Expandable System Design:The ENTRON-EXX features a highly expandable design, enabling quick module additions and swapping. This system can seamlessly adapt to evolving needs, providing customers with an optimized environment for both development and mass production.ULVAC, as a "Field of Potentiality for the Future[2],” is committed to pioneering advances in the semiconductor industry through its innovative application of vacuum technology.[1] A Single platform features a single transfer chamber (Core), offering a simple and space-efficient design. A Tandem platform features two transfer chambers (Cores) arranged in sequence, selected for complex process requiring higher productivity.[2] Field of Potentiality for the futureULVAC formulated its "Vision 2032", envisaging an ideal configuration of the ULVAC Group in 2032, while continuing to be a "Field of Potentiality" for the future. This concept is inspired by the physical potentiality that occurs in a vacuum field: changes in energy and matter. It is also the potentiality of change in the individual, which can lead to the potential to change in the spirit animating society. The ULVAC Group is committed to advancing core vacuum and peripheral technologies and understanding the needs of its customers while addressing social challenges, and continuously creating valuable products and technologies.About ULVAC, Inc. Since its founding in 1952, ULVAC, Inc. has been a comprehensive vacuum equipment manufacturer, providing manufacturing equipment, components, analytical instruments, materials, and services based on its core technology - vacuum technology. Working with customers across a wide range of industries, including semiconductors, electronic components, displays, automotive, and pharmaceuticals, ULVAC is committed to driving cutting-edge innovation and creating new value. For the fiscal year ending June 2024, the ULVAC Group recorded consolidated sales of 261.1 billion yen and has approximately 6,200 employees. For more information, please visit our official website at https://www.ulvac.co.jp/en/For more information:ULVAC, Inc. Strategic Planning DepartmentTEL: +81-467-89-2023Inquiry Form: https://www.ulvac.co.jp/en/contact/general.html Copyright 2024 JCN Newswire via SeaPRwire.com.
More

厦门象屿:债权转让事项落定,公司资产结构优化

EQS 新闻 via SEAPRWire.com / 2024-12-02 / 09:00 UTC+8 11月29日晚,厦门象屿公告称,控股股东象屿集团拟整体受让公司对江苏德龙及其子公司的债权,受让价格为89.74亿元。截至2024年7月31日,公司对江苏德龙债权账面余额为89.74亿元,账面债权评估值为89.74亿元,由于该等债权对应的担保物截至2024年7月31日市场总价值大于债权账面价值,故以账面值作为债权评估值。根据债权转让协议,受让价款将在协议生效后分三期结算。 公告称,本次债权转让有利于公司进一步优化资产结构,切实维护公司及全体股东的利益,不会对公司经营管理和财务状况产生重大不利影响。 此外,公司当晚同步披露三份公告,分别是:取消参与投资忠旺集团铝主业资产等重整资产、变更董事长及法定代表人、向特定对象发行股票的申请获上交所审核通过。 厦门象屿表示,公司在统筹考虑各相关方反馈意见的基础上,结合最新情况更新投融资规划安排,经董事会审议决定取消本次投资。公司控股股东象屿集团将继续作为重整投资人,收购并控股新忠旺集团(忠旺集团铝主业资产设立的新公司)。控股股东进一步布局铝产业制造业,重整后的新忠旺集团与上市公司未来预计将有更多的产业协同与业务合作,有望成为上市公司在铝供应链上的新增长引擎。 厦门象屿本次定向增发对象为招商局集团、山东港口集团及象屿集团,拟募集资金人民币32.2亿元,用于补充流动资金及偿还债务,可以更好满足日常资金周转需要,增强公司资金实力,提高抗风险能力,降低财务风险和经营风险。通过引入招商局集团、山东港口集团作为战略投资者,公司可以实现优势互补,通过深化双方战略合作,达成互利互惠和合作共赢。 厦门象屿主要从事大宗供应链服务,以制造业企业为核心客户,为其提供大宗原辅材料采购供应、产成品分销、物流配送、信息咨询等的一体化供应链服务。公司在2024年半年报中表示,2023年至今,公司经营业绩受到冲击,但以服务制造业客户为核心的业务模式展现出较强的自我修复力和发展韧性。随着政府宏观调控力度加强,宏观经济更加平稳、积极运行,通过持续优化商品组合、客商结构和业务结构,强化风险控制,公司有信心在产业周期波动中,破解发展瓶颈,稳固业务基本盘,重回高质量发展道路。 2024-12-02 此财经新闻稿由EQS Group via SEAPRWire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php
More
蓝色监狱电影版大热,全球票房突破2330万美元! Finance

蓝色监狱电影版大热,全球票房突破2330万美元!

(SeaPRwire) - 这部热门动漫的粉丝们有很多值得期待的事情,因为该系列正在不断发展壮大 洛杉矶, 2024年11月29日 — 今日,Bandai Namco Filmworks Inc. 与 Kodansha Ltd. 宣布,《蓝色监狱剧场版 - EPISODE NAGI -》在全球票房收入超过2330万美元(36亿日元)。该片在87个国家和地区上映,海外票房收入推动影片突破这一里程碑,截至10月份,其国际票房收入已超过日本国内票房收入。随着《蓝色监狱》第二季的播出,Bandai Namco Filmworks Inc. 和 Kodansha Ltd. 计划继续大力开展该足球系列的国际宣传工作。 国际商品销售和宣传工作 各种各样的商品和游戏体验让《蓝色监狱》动漫和漫画的粉丝们能够尽可能多地参与到这个热门系列中,尤其是在全球20多个国家/地区出版了20多种语言的译本。Bandai Namco Filmworks负责亚洲地区的授权,Kodansha负责欧洲、美国和其他地区的授权;并且正在积极开发本地化产品。仅在亚洲,授权规模(商品申请数量)已大幅增长(约四倍),销售额(制作委员会收入)约增长了十二倍,与日本国内的商品收入不相上下。在亚洲,提供《蓝色监狱》商品和收藏品的快闪店尤其受欢迎。 以美国为中心的宣传工作多种多样,而且非常成功。在2024年的动漫博览会上,《蓝色监狱》的每个小组讨论都有超过2000名粉丝参加,座无虚席。这个难得的机会让粉丝们听到演员、制作人和漫画编辑谈论这个系列,受到了与会者热烈的反响。此外,《蓝色监狱VS日本U-20》也在洛杉矶足球俱乐部(LAFC)本赛季的几场比赛中进行了宣传,标志着该俱乐部首次宣传日本动漫。 展望未来 《蓝色监狱》的成功不仅源于全球足球粉丝群体的壮大,也源于其独特的主题和鲜明的角色。《蓝色监狱》的结构更像一场“死亡游戏”,而不是一个体育系列,它既有引人入胜的动作场面,又探讨了诸如个性本质以及如何在竞争中建立人际关系等难题。 国际《蓝色监狱》粉丝们可以期待《蓝色监狱》媒体的持续同步发布以及更多活动,因为Bandai Namco Filmworks和Kodansha仍然致力于将这样精彩的故事带给全球观众。 关于《蓝色监狱》:《蓝色监狱》是一部基于同名热门漫画的电视动画系列,该漫画在讲谈社的《周刊少年杂志》上连载。《蓝色监狱》漫画在全球销量已超过4000万册(截至2024年8月),并获得了第45届讲谈社漫画奖少年部门奖。第一部电影版“蓝色监狱剧场版 - EPISODE NAGI - ”于2024年4月上映。此外,该剧的第二季已于2024年10月5日开始播出 关于Bandai Namco Filmworks Inc.Bandai Namco Filmworks致力于开发和制作电影及视频作品。我们不仅通过电视、电影院和互联网流媒体等各种媒体发行这些作品,还通过授权和管理版权、开发和营销电影及视频相关商品以及其他服务,将它们带给全世界的粉丝。作为一家处理电影和视频业务全过程的综合性娱乐企业,我们将继续创作“精彩的作品”,并让每个人都能轻松获得。 官方网站: 关于讲谈社讲谈社有限公司总部位于东京,是日本领先的出版公司,通过各种各样的内容,从漫画到小说、时尚杂志、新闻期刊和儿童图画书,以及电子游戏和动漫系列电影,将故事传递到世界各地。讲谈社有限公司成立于1909年,致力于“激励不可能的故事”,并作为一些世界上最受欢迎的漫画IP的授权方而享誉全球,其中包括“AKIRA”、“进击的巨人”和“攻壳机动队”。 更多信息,请访问:/ 更多信息,请访问:官方网站:官方X (Twitter): (官方英文账号– Instagram:()– X:()– TikTok:() 可下载其他图像素材: 来源 Bandai Namco Filmworks Inc.本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
安大略彩票及博彩公司 – 中午彩票中奖号码 – 2024年11月29日 Finance

安大略彩票及博彩公司 – 中午彩票中奖号码 – 2024年11月29日

(SeaPRwire) - 多伦多, 2024年11月29日 – 星期五 2024/11/29 PICK-2: 7 0 PICK-3: 2 3 8 PICK-4: 5 7 0 2 ENCORE: 6655467 每日肯诺彩票 (DAILY KENO) 5, 6, 11, 19, 20, 26, 27, 28, 30, 34, 37, 40, 45, 46, 47, 51, 57, 59, 63, 68. 来源 OLG Winners本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
Tetherball 梗币 ($TBALL) 推出 Athena.tball:一款支持社区参与的 AI 驱动机器人
“` Finance

Tetherball 梗币 ($TBALL) 推出 Athena.tball:一款支持社区参与的 AI 驱动机器人 “`

(SeaPRwire) - $TBALL:超级效用币——一种混合型迷因-效用加密货币,用于支付 怀俄明州夏延市,2024年11月29日 — Tetherball Memecoin ($TBALL),一个由女性领导和支持的加密货币,已推出Athena.tball,这是一个创新的AI驱动型机器人,旨在增强加密货币生态系统内的社区参与和教育。 作为超级效用币,$TBALL弥合了迷因币和效用型代币之间的差距,提供现实世界的支付应用、可扩展的区块链解决方案以及一个旨在实现长期创新的强大生态系统。$TBALL将迷因代币的趣味性和文化吸引力与实用功能相结合,将自身定位为一种超越传统预期的混合型加密货币。随着Athena.tball的推出,Tetherball继续履行其将尖端人工智能与区块链技术相结合的使命,增强用户互动并促进积极的社区参与。 “$TBALL代表了区块链效用和AI驱动型社区创新的独特融合,”风险投资家兼Tetherball Memecoin支持者Jenny Q. Ta表示。“Athena.tball展示了人工智能如何通过促进参与和教育来增强区块链生态系统。作为一个AI驱动的机器人,它改变了我们与社区联系以及教育$TBALL持有者和更广泛的加密世界的方式。” Athena.tball:增强社区参与Athena.tball是一个强大的工具,通过支持社交媒体互动和生成引人入胜的内容来促进$TBALL生态系统内更深层次的联系。在机器学习自动化专家Zack Adams的领导下开发,Athena.tball的主要功能包括: 自主社交媒体参与:独立生成推文并回应社区互动。 迷因分享:利用精心策划的迷因库,并计划为贡献者提供奖励。 情绪分析:根据积极、中性或消极情绪调整语气。 上下文感知:与用户进行相关且有意义的对话。 自我识别:在大多数互动中保持对其身份的认知。 虽然其他工具,例如Truth Terminal的$GOAT机器人,已经引起了关注,但Athena.tball通过融合幽默、教育和自我意识而与众不同。这些独特的品质使其成为$TBALL生态系统的动态资源。 机器学习自动化专家Zack Adams表示:“这些功能使Athena.tball能够培养一个知情且参与的社区,同时推广$TBALL在教育和创新方面的价值观。“她不仅仅是互动——她学习、教育和娱乐。如果你没有学习,你就在笑;如果你没有笑,你就在学习。” 人工智能生态系统战略家Jennifer Strout评论道:“Athena.tball是区块链创新和有意义的社区互动之间的桥梁。她旨在参与和教育,为$TBALL的未来奠定坚实的基础。”Jennifer在将AI集成到面向客户和后端系统方面拥有丰富的经验。她的作品曾在CNBC和亚马逊Prime上展出,并在Apple iOS应用商店的十大排行榜上名列前茅。从计算机视觉到自然语言处理,Jennifer继续为不断发展的行业实施可持续的增长解决方案。 关于Tetherball Coin ($TBALL)Tetherball Coin ($TBALL)是第一个由女性领导和支持的固定供应加密货币,设计为一种混合型迷因-效用AI驱动的数字资产。它专注于教育、创新和社区驱动的价值。由Solana的高性能区块链提供支持,$TBALL作为日常服务和订阅的交易币,在加密货币领域提供了一种有意义的替代方案。 更多信息,请访问 或关注 on X (formerly Twitter)。 媒体联络:Kuan-Ning Tseng联合创始人213-436-6467 来源 Tetherball Memecoin本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
Frontenac Mortgage Investment Corporation就加拿大邮政罢工期间的特别会议材料提供更新
“` Finance

Frontenac Mortgage Investment Corporation就加拿大邮政罢工期间的特别会议材料提供更新 “`

(SeaPRwire) - 安大略省沙博特湖, 2024年11月29日 – Frontenac Mortgage Investment Corporation (“FMIC” 或“公司”) 今日宣布,由于加拿大持续的邮政罢工(“罢工”),发送或实物递送管理信息通函(“通函”)、委托书和投票信息表及相关文件(统称为“会议材料”)给股东可能会延迟,FMIC 股东特别会议将于2024年12月18日下午2点(东部标准时间)在DoubleTree Hotel,1550 Princess St., 安大略省金斯顿 K7M 9E3 举行,并通过meetnow.global/MD9F99Y 进行在线直播(“特别会议”)。 在特别会议上,将请股东就以下事项投票:(i)一项特别决议,批准根据更详尽地载于通函第13至19页的秩序解散计划,对公司进行秩序解散;以及(ii)一项特别决议,确认并批准对FMIC公司章程的修订,以实施更详尽地载于通函第19至21页的按比例赎回计划。 为了便于在罢工或相关事件阻止、延迟或以其他方式中断会议材料的实物递送的情况下向股东递送会议材料,公司鼓励股东通过电子方式访问会议材料。会议材料已提交,可在SEDAR+ 上公司的资料档案中查阅,并张贴在公司的网站上。此外,股东可以通过以下方式访问会议材料的电子版: 在Computershare的网站上;或 向W.A. Robinson Asset Management Ltd.索取,地址:14216 Road 38, 安大略省沙博特湖 K0H 2P0,电话:1-877-279-3061 分机105,或发送电子邮件至 。 希望通过委托投票参加会议的股东可以联系Computershare Trust Company 获取其控制号码,并可以通过访问 在线投票,或通过电话投票(1-866-732-8683)进行投票。投票指示表或委托书必须在2024年12月16日下午4点(东部标准时间)之前送达公司,或者,如果特别会议延期或推迟,则必须在延期或推迟时间之前的48小时(不包括星期六、星期日和节假日)之前送达。 如果您有任何关于如何获得您的个人控制号码的问题,或者需要了解如何以不需要使用邮政服务的方式向公司提交委托书或投票指示,请拨打Computershare免费电话1-866-732-8683。 公司董事会鼓励股东投票,并在投票前仔细阅读并完整了解通函。 有关FMIC的更多信息,请访问SEDAR+ 上FMIC的资料档案:。 前瞻性陈述 本新闻稿包含某些前瞻性陈述和前瞻性信息(在此统称为“前瞻性陈述”),其含义符合适用的加拿大证券法,其中可能包括但不限于有关或推断公司未来业务、运营、财务业绩、前景及其他计划、意图、预期、估计和信念的信息和陈述。除关于现在或过去事实的陈述外,所有陈述均为前瞻性陈述。前瞻性陈述通常(但并非总是)通过使用诸如“预期”、“实现”、“可能”、“相信”、“计划”、“打算”、“目标”、“持续”、“正在进行”、“估计”、“展望”、“期望”、“可能”、“将”、“预测”、“应该”或类似词语(包括其否定形式)来识别,这些词语暗示未来的结果。 前瞻性陈述涉及并受制于假设以及FMIC无法预测或控制的已知和未知风险、不确定性和其他因素,这些因素可能导致FMIC的实际事件、结果、业绩或成就与本文件中前瞻性陈述明示或暗示的未来事件、结果、业绩和成就存在重大差异。前瞻性陈述并非未来业绩的保证。尽管FMIC认为本文件中的任何前瞻性陈述在考虑到使用的假设以及此类陈述中固有的重大风险和不确定性的情况下是合理的,但不能保证任何此类前瞻性陈述将被证明是准确的。实际结果可能与本文件中前瞻性陈述明示或暗示的结果有所不同,并且可能存在重大差异。因此,建议读者依靠他们自己对本文件中前瞻性陈述中固有的风险和不确定性的评估,并且不应过分依赖此类前瞻性陈述。本文件中的所有前瞻性陈述均受此警示性声明的限制。本文件中的任何前瞻性陈述仅在本文件发布之日作出,除非适用法律要求,否则FMIC不承担任何义务,也不打算更新或修改本文件中的任何前瞻性陈述,或更新实际事件或结果可能或确实与本文件中的任何前瞻性陈述中预测的结果不同的原因,无论是由于新信息、未来事件或结果,还是其他原因。 来源 Frontenac Mortgage Investment Corporation本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
从厨余垃圾到飞机燃料:中国令人惊叹的能源解决方案 Finance

从厨余垃圾到飞机燃料:中国令人惊叹的能源解决方案

(SeaPRwire) - 北京, 2024年11月30日 — 这篇报道来自 China.org.cn。 用过的食用油也是清洁能源吗?哪些能源可以使我们的世界更清洁?整个供应链是什么样的?我们的主持人Jason在第二届中国国际供应链博览会(CISCE)上度过了令人大开眼界的一天。 Jason没想到会在CISCE的清洁能源展区找到用过的食用油。北京海鑫能源科技有限公司可以将用过的食用油转化为加氢处理的植物油(HVO)。与柴油混合后,可用于汽车、船舶和飞机。第一个试点项目位于北京海淀区,形成从收集到再利用的闭环系统。 中国石化展示了大型双压液驱动氢压缩机,这是中国最大的同类设备。它将为中国石化在沧州的新建加氢站提供动力,为100多辆重型卡车加氢。这每年可节省5000多吨碳排放,相当于种植500公顷树木,约等于700个足球场的大小!而中国石化正在建设从生产到加氢站的完整氢能源网络。 中国海洋石油总公司(CNOOC)的LNG罐储存液化天然气(LNG)。天然气保持在极低的温度,零下162度。这种极低的温度实际上非常有用。它可以用于养鱼场、冷库,甚至室内雪场。它就像免费的空调。 东方汽轮机有限公司展示了中国首台自主研发的F级50兆瓦重型燃气轮机。它每小时发电50000千瓦时,足以供应7000户家庭一天的用电。它每年减少二氧化碳排放50万吨,相当于每年450万棵树木吸收的二氧化碳量。该燃气轮机拥有超过20000个零件。该公司与大学、科研机构和300多家企业合作,其中39家是专业的高科技企业。 在这里您可以看到上游、中游和下游公司。在CISCE这个开放平台上,全球供应链变得更加顺畅。 来源 China.org.cn本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
Military Metals Issues Invitation to Tender for Resource Estimation at Its Trojarova Antimony-Gold Property in Slovakia ACN Newswire

Military Metals Issues Invitation to Tender for Resource Estimation at Its Trojarova Antimony-Gold Property in Slovakia

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - November 25, 2024) - Military Metals Corp. (CSE:MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") has issued an invitation to tender bids for carrying out a mineral resource estimation at the Company's Trojarová antimony-gold property in Slovakia. Three companies with recognized technical credentials were selected to submit bids.Trojarová, located in the heart of Europe, had prior development and production operations in respect of antimony. Historical resource estimates were produced in connection with Soviet era work conducted on the property, in accordance with the Russian classification system at the time. Please refer to the Company's news release dated October 30, 2024 for more detailed information about this antimony-gold deposit and the prior estimates. The historical work conducted is instructive as to future work programs to be conducted by the Company.The Company expects to receive bids by December 20, 2024 and to make a decision by year's end as to which company it will commission with a three-fold task:Input all historical data into a digital data base, including drill logs and analyses, plans, section, underground geological mapping and sampling, historical block modeling and all other relevant data, in order to generate an independent three-dimensional model and seek to verify the accuracy of the historical estimates on the property:Make recommendations to management in regard to the number, location, orientation and depth of twin and infill holes to be drilled, along with all quality assurance, quality control protocols, in order that the non-compliant historical resource can be upgraded and classified as a mineral resource in accordance with current industry standards;On completion of the new drill program outlined in items 1 and 2 above, input all newly generated drill data and prepare a "maiden" mineral resource estimate.Management eagerly awaits receipt of bids and then plans to move forward with the above three step program. With continuation of high antimony prices and demand, management believes that conducting work on Trojarová can add significant value for shareholders.The technical contents of this release were reviewed and approved by Avrom E. Howard, MSc, PGeo, geological consultant to Military Metals and a qualified person as defined by NI 43-101.About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD of DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.comFor enquiries, please call 604-722-5381 or 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release includes statements related to the filing of a NI 43-101 compliant technical report, activities related to the classification of mineralization documented at Trojarova as a current mineral resource, work to be conducted by the successful bidding party for the work described in the news release, future drill programs and other exploration work, and any future plans for activities at Trojarova. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, future prices of antimony, availability of capital and labour in respect of Trojarova, any required approvals related to exploration activities to be conducted, the completion of successful bids as part of the process outlined in the news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact any future activities in respect of the properties held by the Company. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231241 Copyright 2024 ACN Newswire via SeaPRwire.com.
More
华领医药宣布成功完成在美国开展的第二代葡萄糖激酶激活剂I期临床研究 ACN Newswire

华领医药宣布成功完成在美国开展的第二代葡萄糖激酶激活剂I期临床研究

上海, 2024年11月30日 - (亚太商讯 via SeaPRwire.com) - 华领医药("公司",香港联交所股份代号:2552.HK)今天在第九届中国医药创新与投资大会(The China BioMed Innovation and Investment Conference,以下简称CBIIC)上宣布,已经成功完成在美国开展的第二代葡萄糖激酶激活剂(GKA)的Ia临床研究。第二代GKA(HM-002-1005)Ia临床试验是在美国40例2型糖尿病(T2D)受试者中进行的随机、双盲安慰剂对照、单剂量、安全性、耐受性、药代动力学研究。第二代GKA是一种具有优化的理化性质的新分子实体,拥有新专利,为多格列艾汀(HMS5552)前药。该项研究设计为每日一次口服给药,旨在通过缓释技术来延长药物在体内的作用时间、改善患者依从性以及延长刺激肠道内GLP-1分泌的效果。这一单次剂量递增(SAD)研究结果显示,HM-002-1005片在人体内可迅速转化为HMS5552,前药在血浆和尿液中的暴露量极低。HM-002-1005片单次给药后的t1/2(生物半衰期)相较于多格列艾汀片延长。184.5mg单次给药后,血浆中HMS5552的Cmax与多格列艾汀片75mg单次给药后的血浆HMS5552浓度相当;同时,血浆中HMS5552的单日AUC与多格列艾汀片75mg一天两次给药后HMS5552的暴露水平相当。该研究表明,HM-002-1005片在人体内几乎完全转化为HMS5552,且其药代动力学特征支持每日一次口服给药方式。HM-002-1005片的开发不仅有利于提高患者服药的依从性,实现24小时内有效控制血糖;同时,也为探索每日150mg以上的最大耐受剂量提供了机会,以获得更好的治疗效果。多格列艾汀75mg每日两次(BID)剂量是根据最低有效治疗剂量的治疗理念,针对中国2型糖尿病患者普遍存在的胰岛素分泌缺陷和早相胰岛素分泌显著降低而开发的剂型。西方2型糖尿病患者具有不同的疾病特点,往往合并肥胖症状,多格列艾汀能够促进GLP-1分泌、改善胰岛素敏感性,有望为该患者群体带来新的获益。该研究结果确认HM-002-1005片184.5mg的暴露水平与多格列艾汀片75mg BID相当,公司将进一步优化剂型,在中国和美国进行第二代GKA的多次递增剂量(MAD)临床开发。华领医药创始人、CEO陈力博士表示:"华领医药始终致力于通过修复患者血糖自主调控能力,从源头上治疗2型糖尿病。公司历经十年,选择了针对大多数中国糖尿病患者安全有效的用药剂量方案和临床研究方案,实现了GKA的成功开发和多格列艾汀的临床应用。在此基础上,公司将进行战略升级,通过继续探索GKA的用药潜力、丰富产品管线,在国内外寻求合作伙伴,惠及更多患者人群、拓展全球市场,更好地实现GKA药物的品牌建设和全球首创新药的商业价值。"关于华领华领医药("本公司")是一家总部位于中国上海的创新药物研发和商业化公司,在美国、中国香港设立了公司。华领医药专注于未被满足的医疗需求,为全球患者开发全新疗法。华领医药汇聚全球医药行业高素质人才,融合全球创新技术,依托全球优势资源,研究开发突破性的技术和产品,引领全球糖尿病医疗创新。公司核心产品华堂宁(R)(多格列艾汀片)以葡萄糖传感器葡萄糖激酶为靶点,提升2型糖尿病患者的葡萄糖敏感性,改善患者血糖稳态失调。2022年9月30日,华堂宁(R)已获得中国国家药品监督管理局(NMPA)的上市批准,用于单独用药或者与二甲双胍联合用药,治疗成人2型糖尿病。对于肾功能不全患者,无需调整剂量,是一款可用于肾功能损伤的2型糖尿病患者的口服降糖药物。详情垂询华领医药网址:www.huamedicine.com投资者电邮:ir@huamedicine.com媒体电邮:pr@huamedicine.com Copyright 2024 亚太商讯 via SeaPRwire.com.
More
华领医药宣布成功完成在中国香港开展的SENSITIZE研究 ACN Newswire

华领医药宣布成功完成在中国香港开展的SENSITIZE研究

上海, 2024年11月30日 - (亚太商讯 via SeaPRwire.com) - 华领医药("公司",香港联交所股份代号:2552.HK)今天在第九届中国医药创新与投资大会(The China BioMed Innovation and Investment Conference,以下简称CBIIC)上宣布,公司已经成功完成与香港中文大学Juliana Chan教授团队合作开展SENSITIZE研究,该研究为多格列艾汀改善β细胞葡萄糖敏感性的作用机制研究。SENSITIZE研究是由国际内分泌专家、香港中文大学Juliana Chan教授作为研究者发起的,首个在亚洲人群中采用高葡萄糖钳夹技术评估GKA对不同血糖调节受损人群的β细胞葡萄糖敏感性影响的临床研究,以探索不同葡萄糖激酶(GK)功能损伤类型在血糖失调方面的临床特征和干预手段,为研究亚洲T2D病生理及GK在血糖调控中的核心作用提供了新的科学依据。此次报告的SENSITIZE 2研究结果显示,采用高葡萄糖钳夹技术,多格列艾汀单次给药修复GK酶活性,显著改善葡萄糖耐量异常(IGT)人群的二相胰岛素分泌和β细胞葡萄糖敏感性。而此前在2022年美国ADA年会上报告的SENSITIZE 1研究结果显示,多格列艾汀可直接修复临床纳入的GK突变型活性,可以显著改善葡萄糖激酶单基因遗传突变糖尿病 (GCK-MODY或MODY-2)患者的胰岛素第二时相分泌和β细胞葡萄糖敏感性,可以显著改善初发2型糖尿病患者的基础胰岛素分泌。华领医药还将继续研究多格列艾汀多次给药对中间高血糖(IH)和2型糖尿病患者β细胞葡萄糖敏感性的修复作用,以及对肠促胰岛素的作用,从而建立糖尿病前期和2型糖尿病患者的个性化干预和治疗管理方案。关于华领华领医药("本公司")是一家总部位于中国上海的创新药物研发和商业化公司,在美国、中国香港设立了公司。华领医药专注于未被满足的医疗需求,为全球患者开发全新疗法。华领医药汇聚全球医药行业高素质人才,融合全球创新技术,依托全球优势资源,研究开发突破性的技术和产品,引领全球糖尿病医疗创新。公司核心产品华堂宁(R)(多格列艾汀片)以葡萄糖传感器葡萄糖激酶为靶点,提升2型糖尿病患者的葡萄糖敏感性,改善患者血糖稳态失调。2022年9月30日,华堂宁(R)已获得中国国家药品监督管理局(NMPA)的上市批准,用于单独用药或者与二甲双胍联合用药,治疗成人2型糖尿病。对于肾功能不全患者,无需调整剂量,是一款可用于肾功能损伤的2型糖尿病患者的口服降糖药物。详情垂询华领医药网址:www.huamedicine.com投资者电邮:ir@huamedicine.com媒体电邮:pr@huamedicine.com Copyright 2024 亚太商讯 via SeaPRwire.com.
More
把握政策机遇 推进高质量及可持续发展战略 ACN Newswire

把握政策机遇 推进高质量及可持续发展战略

- 天然气总销量达171.3亿立方米;- 累计接驳居民、工业和商业用户分别达到4,795.6万户、2.6万户及38.5万户;- 天然气顺价加快落地 销气毛差同比上涨0.02元/m³至0.59元/m³;- 增值服务经营性利润同比增长15.4%至10.0亿港元;- 财务状况稳健,财务资源丰富,自由现金流达22.2亿港元,备用银行授信及获批准的人民币债券总额约1,049.1亿等值港元;- 中期派息每股15.0港仙。财务摘要 截至9月30日止六个月 20242023变化千港元千港元%收入35,105,20236,049,154(2.6) 天然气销售19,641,83621,718,489(9.6) 燃气接驳2,027,0382,308,096(12.2) 工程设计、建设及施工 1,308,4871,056,41223.9 液化石油气(「LPG」)销售9,557,9768,421,66313.5 增值服务 2,012,9951,804,48611.6 其他业务556,870740,008(24.7)毛利5,855,6955,723,5732.3期间溢利2,263,9152,107,2037.4每股盈利(港仙)32.734.0(3.8)每股中期股息(港仙)15.015.0- 20249月30日20243月31日 变化千港元千港元%总资产153,473,528148,697,7243.2权益总额64,165,44260,747,3535.6银行结余及现金9,421,5978,280,33513.8香港, 2024年11月30日 - (亚太商讯 via SeaPRwire.com) - 国内具有领先地位的城市燃气营运商中国燃气控股有限公司(「中国燃气」或「集团」;股票编号:384)宣布其截至2024年9月30日止(「报告期」)之上半财年业绩。报告期内,为适时应对复杂多变的国际政治和经济形势,中国政府于九月开始推出稳定经济的措施。在一揽子有利政策的推动下,内地宏观经济有望持续回升向好,同时亦为提振天然气消费需求创造有利条件,城市燃气企业的盈利能力有望迎来修复,进入一个崭新发展期。此外,天然气上下游价格联动机制在全国范围内逐步落地,更多地区实现居民终端销售价格调整,销气毛差逐渐修复,进一步支撑天然气行业的健康及可持续发展。集团秉承"促回款、扩毛差、降费用、强组织、提品质、谋发展"的经营理念,积极探索创新业务的增长新路径,实现以燃气业务、增值服务、综合能源三大核心业务板块的协同发展。期内,集团录得营业额351.1亿港元,天然气售气总量达171.3亿立方米,自由现金流表现稳健,达22.2亿港元。董事会通过派付上半财年股息每股15.0港仙(2023/24年上半财年:15.0港仙),以回馈广大股东对集团的长期支持。加快天然气顺价落地,顺价比例及毛差进一步提高期内,集团抓住政策机遇,积极响应国家出台的天然气上下游价格联动机制及配气价格成本监审等政策,推动各地加快顺价,集团经营区域内新增20个市/县落实调价。截至2024年9月30日,集团累计完成居民气量顺价比例达62.2%,毛差修复至0.59元/m³,与去年相比取得稳步提升。期内,借助"老旧小区改造"和"瓶改管"等政策红利,新接驳904,232户居民用户、1,316户工业用户及24,906户商业用户。截至2024年9月30日,集团累计共为47,955,499户居民用户、25,792户工业用户及384,504户商业用户提供天然气服务,分别较去年同期增长约3.2%、10.7%和11.6%;集团城市燃气项目覆盖的可接驳户数达5,460万户。截至2024年9月30日,集团累计共于30个省、市、自治区取得662个拥有专营权的管道燃气项目,并拥有32个天然气长输管道、509座压缩/液化天然气加气站、一个煤层气开发项目及120个液化石油气分销项目。LPG业务保持高质量发展,持续优化纵向一体化协同作为中国规模最大、产业链最完整的综合性LPG运营服务商,集团业务覆盖全国22个省、市、自治区,目前运营5座液化石油气专用码头及6座大型石化产品仓储物流基地,码头年吞吐能力超过1,000万吨,总库容超过80万立方米。期内,集团实现销售液化石油气201.8万吨,销售收入总额达到95.6亿港元。集团持续优化纵向一体化协同,就上游而言,集团积极推进核心能力建设,提升国际贸易业务能力。期内,集团重构国际贸易团队和贸易风控体系,设立新加坡国际直采平台,在国际贸易业务方面取得实质性突破。于中游,集团推进仓储物流市场化运作,实现仓储物流资源整合,逐步提升仓储周转率,同时启动国内运贸平台建设,利用数字化赋能,扩大国内分销能力,从而提高国内分销与仓储物流效益。在下游端,集团推动创新业务模式与轻资产模式有效结合,通过迭代优化终端投资模式,丰富投资工具,助力终端业务高质量发展。增值服务营收利润双增长,未来发展空间巨大基于家庭场景,集团增值服务布局3大传统产品板块(厨房产品、安防产品、其它产品及服务)及4大新产品板块(电器、宜居、到家、优选)。目前增值服务业务遍及全国26个省、市、自治区,为用户提供产品及服务,不断增加用户覆盖,拓宽销售渠道。今年以来,中国消费市场保持稳定增长态势,政府出台多项政策鼓励家电以旧换新和家装消费品换新工程。集团把握政策机遇,于期内通过加快渠道建设、优化运营策略和强化终端赋能,实现增值服务收入同比增长11.6%至20.1亿港元;经营性利润同比增长15.4%至10.0亿港元。目前,集团通过不断深化传统渠道运营策略,优化产品结构,加快新业务拓展步伐,借助国家消费扶持政策,进一步扩大市场规模,未来发展空间巨大。积极探索综合能源业务商业模式,推进重点业务发展集团坚持以"绿色城市运营商"为战略定位,有效推进多业态融合、优化低能源成本综合方案以拓展市场、落地可长期发展的多赢商业模式。集团充分利用自身燃气项目的巨大市场和用户优势,通过外延式及内生性增长提升综合能源业务市场份额。期内,集团积极探索综合能源业务发展模式,锚定发展重点,投资及运营工商业用户侧储能、分布式光伏、锅炉节能、工商用户节能、建筑能效、充电桩、生物质能等业务。同时积极参与售电业务,并带动绿电绿证、碳排放因子库、虚拟电厂等业态快速扩充,为客户提供高效率的综合能源,满足客户对气、热、电、冷的不同需求。期内,储能及综合能效业务累计实现签约总装机容量318.4MWh,累计投建255.8MWh;售电业务交易量28.1亿度;绿证绿电业务完成销售8,196.4MWh。持续提升安全管理能力,积极推进老旧燃气管道等设施整改工作集团始终将安全管理视为核心任务,全面识别潜在风险,认真落实隐患整改,持续提升安全管理能力,为集团高质量发展营造安全稳定的环境。期内,集团通过开展专项治理工作,进一步规范基层员工操作,提升员工业务水平,并加强对燃气管道和相关设施关键信息的系统性收集,提升对管网资产的管理水平。同时,借助国家政策支持,集团积极推进老旧燃气管道和用户设施老化的更新改造与维护工作。此外,集团不断加强HSE体系审核认证及体系建设工作,建立健全集团双重预防机制管理模式,加强安全风险管控与隐患排查治理的闭环管理,并通过积极开展评级检查,有效提升了项目公司的安全管理水平。财务状况稳健截至2024年9月30日,集团总资产为1,534.7亿港元;银行结余及现金为94.2亿港元;期内集团通过执行严格的外币债务管理措施,及时合理地调整债务结构。集团一直积极与中国(包括香港)及外资银行建立长远合作关系,备用银行授信及获批准的人民币债券总额约1,049.1亿等值港元。行业发展及展望国际天然气价格在经历两年剧烈波动后,二零二四年以来重现平衡,供需端亦延续宽松态势。9月下旬开始,中国政府推出一系列稳经济、强信心的刺激政策,有助于经济复苏和房地产市场稳定,加上此前推出的"三大工程"、"超长期特别国债"、 "老旧管网更新"、"老旧小区改造"、"瓶改管"等利好燃气行业的政策,有利于稳固燃气行业根基。与此同时,各省市陆续发布和落实天然气上下游价格联动政策,有助于提升销气毛差,保障燃气企业的合理收益,促进天然气行业的健康长远发展。此外,全球低碳转型的浪潮不可阻挡,新能源和综合能源持续发展。集团将紧抓政策机遇,加快促进顺价落地,严控资本开支,推动数字化转型,进一步提升销气量及增值服务盈利水平,并全力推动综合能源项目发展,为国家经济发展提供"绿色"保障。集团主席兼总裁刘明辉先生表示:"随着今年九月中国政府推出一系列旨在稳定市场的货币及财政政策以促进经济长期健康发展,相信更多具体、有力的稳经济政策将陆续出台,这些措施将提振资本市场信心,同时亦为中燃的业务发展提供良好的宏观环境。在宏观经济逐渐向好的大环境下,集团将发挥勇于创新变革的优良传统,不断优化业务模式,坚持高质量发展和可持续发展的策略,在不断做强集团燃气业务的基础上,继续深耕'客户导向'和'价值创造',依托产业链延伸,拓展用户侧储能、生物质能等新业务,积极探索宜居、到家等增值服务新业态。同时,集团亦将把握机遇,紧跟政策、用好政策,缜密筹划,真正把国家政策红利转化为集团发展新动能,实现经营业绩与股东利益的双重增长。"有关中国燃气中国燃气控股有限公司("中国燃气",股票代号:384)是一家领先的燃气运营服务商,主要于中国从事投资、建设、经营城市燃气管道基础设施,向居民及工商业用户输送天然气和液化石油气,建设和经营车船用天然气加气站。同时,在庞大的燃气用户网络基础上,中国燃气打造了增值服务及综合能源并举的全业态发展结构。目前中国燃气在全国已拥有662个城镇的管道燃气专营权项目、32个天然气长输管道项目、509座压缩/液化天然气加气站,以及液化天然气等能源产品的进出口经营权,并拥有120个液化石油气分销项目。如欲获得更多中国燃气的资讯,请登入公司网址http://www.chinagasholdings.com.hk Copyright 2024 亚太商讯 via SeaPRwire.com.
More
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate ACN Newswire

Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate

SHANGHAI, Nov 30, 2024 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China BioMed Innovation and Investment Conference (CBIIC).The Phase Ia clinical trial of the second-generation GKA (HM-002-1005) was conducted in the United States in 40 subjects with Type 2 diabetes (T2D). This trial was randomized, double-blind, placebo-controlled, single-dose, focusing on safety, tolerability, and pharmacokinetics. The second-generation GKA is a novel molecular entity with optimized physicochemical properties, holding new patents, and serving as the prodrug of dorzagliatin (HMS5552). This study designed for once-daily oral administration. Its aim is to extend the drug's action duration in the body through sustained-release technology, enhance patient compliance, and prolong the stimulation of GLP-1 secretion in the intestines.The Single Ascending Dose (SAD) study demonstrates that HM-002-1005 tablets can be rapidly converted to HMS5552 in the human body, with minimal exposure level of prodrug in both blood and urine. The t1/2 (biological half-life) after a single dose of HM-002-1005 tablets was prolonged compared to dorzagliatin tablets. The Cmax of HMS5552 in plasma after a 184.5mg single dose is comparable to the plasma concentration of HMS5552 after a 75mg single dose of dorzagliatin tablet; likewise, the daily AUC of HMS5552 in plasma after a single dose of HM-002-1005 tablets is comparable to the exposure level of HMS5552 after a 75mg BID dose of dorzagliatin tablets. The research indicates that HM-002-1005 tablets are near-completely converted to HMS5552 in human, and its pharmacokinetic characteristics support for once-daily oral administration. The development of HM-002-1005 tablets not only contributes to enhancing patient medication adherence and effectively control blood glucose levels within 24 hours; meanwhile, it also offers the opportunity to explore the Maximum Tolerated Dose above 150mg daily to achieve better efficacy. The 75 mg BID dose regiment was developed under the concept of Minimum Therapeutic Effective Dose in Chinese T2D patients who suffered from an impairment of insulin secretion and significant reduction of early phase insulin. The different disease characters of T2D with obesity in western patient population would benefit dorzagliatin from its effects on GLP-1 secretion and improvement of insulin sensitivity.With the confirmation that the exposure level of HM-002-1005 tablets at 184.5mg is comparable to dorzagliatin tablets at 75mg (BID), we will further optimize the dosage form followed by a Multiple Ascending Dose (MAD) clinical development of the 2nd generation GKA in China and the United States.Dr. Li CHEN, founder and CEO of Hua Medicine, stated, “Hua Medicine has always been committed to treating Type 2 diabetes at its root cause by restoring patients’ ability to autonomously regulate blood glucose levels. Over the course of a decade, the Company has selected dosing and clinical research protocols that are safe and effective for the majority of Chinese diabetes patients, leading to the successful development of GKA and the clinical application of dorzagliatin. Building on this foundation, the Company will undergo a strategic upgrade by further exploring the therapeutic potential of GKA, enriching its product pipeline and seeking partners both domestically and internationally, in order to benefit a broader range of patients, expand into global markets, and effectively establish the brand identity of GKA medications while maximizing the commercial potential of our global first-in-class drugs.”About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (Dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC ACN Newswire

Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC

SHANGHAI, Nov 30, 2024 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves the β-cell glucose sensitivity at the 9th China BioMed Innovation and Investment Conference (CBIIC).The SENSITIZE study was initiated by Professor Juliana Chan, an international endocrinology specialist at The Chinese University of Hong Kong, as the lead researcher. It is the first clinical study in Asian populations to evaluate the impact of GKA on β-cell glucose sensitivity in the populations with varying degrees of impaired glucose tolerance using the technology of hyperglycemic clamp. The study aims to explore the impairment of glucokinase (GK) function and clinical characteristics in different types of glucose dysregulation, providing new scientific evidence on the pathophysiology of Asian Type 2 diabetes and the central role of GK in blood glucose regulation.The SENSITIZE 2 study results announced at CBIIC demonstrate that a single dose of dorzagliatin restores GK enzyme activity, significantly improving the second-phase insulin secretion and β-cell glucose sensitivity in individuals with impaired glucose tolerance (IGT) in hyperglycemic clamp study. In addition, the SENSITIZE 1 study previously reported at the 2022 ADA annual meeting showed that dorzagliatin directly restores the activity of GK mutants, leading to significant improvements in the second-phase insulin secretion and β-cell glucose sensitivity in patients with glucokinase monogenic diabetes (GCK-MODY or MODY-2), and significantly enhance basal insulin secretion in newly diagnosed type 2 diabetes patients.Hua Medicine will continue to investigate β-cell glucose sensitivity improvement and incretin effect in response of repeated dose of dorzagliatin in individuals with intermediate hyperglycemia (IH) and Type 2 diabetes, in order to establish personalized intervention and treatment management plans for prediabetic and Type 2 diabetes patients.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (Dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
黑色星期五的真实代价
“` Latest News

黑色星期五的真实代价 “`

(SeaPRwire) - 如果你也是数百万打算在黑色星期五或网络星期一抢购新手机、无线电钻或其他小工具的美国人之一,你可能需要考虑一下那些打折小工具的真实成本。这是因为我们所有人使用的消费电子产品中所含的金属正在导致……甚至…… 当然,不同的设备由不同的材料制成,包括塑料和玻璃。但是,从iPhone到手持式真空吸尘器再到电动牙刷,当今的无线消费电子产品通常包含三个关键的金属部件:电池、充电线和磁铁。这些部件的原材料往往以令人不安的方式采购。 为大多数电子产品供电的锂离子电池由锂(当然)、镍和钴制成。世界上最大的锂来源之一是智利的阿塔卡马沙漠,那里的矿山……许多科学家和土著居民担心他们……家园是稀有火烈鸟的泻湖;为山羊、绵羊和羊驼提供食物的植被;以及阿塔卡梅尼奥土著社区延续数千年的生活方式,可能会…… 在世界的另一边,印度尼西亚近年来已成为主要的镍原材料供应国。为了清理用于新矿山和相关基础设施的土地,仅在一个群岛国家的众多岛屿之一,就有超过20,000英亩的雨林被……砍伐。包括六价铬在内的矿山废物——艾琳·布罗科维奇(Erin Brockovich)曾因其致癌毒性而闻名——已经污染了溪流和水道。一旦开采出来,镍矿石就会在巨大的工业设施中进行加工,这些设施会排放空气污染物并消耗能源,而这些能源大多来自…… 全世界超过……的钴来自刚果民主共和国,这是一个饱受反复内战、地方性腐败和极度贫困困扰的国家。刚果民主共和国最糟糕的矿山简直就是一场噩梦。穿着短裤、T恤和人字拖的男子……在狭窄的地下隧道里度过白天,用手工工具凿出钴。隧道倒塌,活埋矿工的情况并不少见。也许最令人不安的是,刚果民主共和国的钴矿工包括数千名儿童。“孩子们需要经常搬运超过他们体重重量的矿石,”……一群访问过数十座矿山的欧洲研究人员说。孩子们还经常遭到保安的殴打和鞭打。有些孩子只有……岁。 然后是为我们设备的锂离子电池供电的充电线。这些电缆……含有铜,其他常见的电子元件(如印刷电路板和内部布线)也是如此。铜在世界许多地方开采,这很少是一个美好的过程。从美国西部到南美洲到中非,铜矿开采留下了……充满……的废弃矿井,污染了大片土地和水道。这种红色金属也经常引发暴力。近年来,在秘鲁,警方……在与铜矿有关的冲突中……在巴基斯坦俾路支省,对铜资源的争夺正在加剧……在南非,武装团伙大量盗窃铜来卖给回收商,有时会……那些干扰他们的人。 我们很少看到第三种金属部件:钕基“永磁体”,它使无线电钻旋转,手机振动,并在耳机和笔记本电脑扬声器中发出声音。中国……稀土的生产,稀土是一类金属,其中包括钕。他们对稀土的控制如此之大,以至于2010年北京……对日本短暂……时,它给全球经济带来了冲击波。中国主要的稀土矿区是污染最严重的地区之一。中国还从缅甸进口越来越多的稀土,缅甸……用大量有毒化学物质从丛林山坡上开采稀土。 所有这些都加剧了各种金属开采产生的巨大碳排放。矿山需要大量的钻机、卡车、挖掘机和其他重型机械,这些能源消耗大户占世界年度温室气体排放量的…… 除了黑色星期五之外,我们对电子产品的沉迷造成的后果已经够糟糕了。随着消费者投入数百甚至数千美元,每年的购物狂欢节的销售额持续增长。而且……这些购买的大部分最终都进入了垃圾填埋场或焚烧炉。在美国,每年只有不到……的报废手机被回收。 我们能做些什么来降低这些可怕的成本?考虑购买二手或翻新的电子产品,以帮助减少对原生金属的需求。并帮助向制造商施压,促使他们使用更多再生材料。他们开始关注了:今年Apple和Samsung的手机都使用了创纪录数量的……和钕。 但作为消费者,我们所能做的最有影响力的事情很简单:抵制促销的诱惑,不要购买太多小工具。这可能是最好的交易。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
Bybit x Block Scholes 衍生品报告:ETH 表现优于 BTC Finance

Bybit x Block Scholes 衍生品报告:ETH 表现优于 BTC

(SeaPRwire) - 迪拜, 阿联酋, 2024年11月28日 — ,全球交易量第二大的加密货币交易所,与Blocks Scholes合作,发布了最新的每周衍生品分析报告,并发现了表明ETH在过去一周的表现超过BTC的信号。 受美国证券交易委员会(SEC)现任主席Gary Gensler将在拜登政府任期结束时离职的消息推动,ETH的表现令投资者感到惊喜。特别是,ETH永续合约的未平仓合约一直在增加。几只大型山寨币也受益于Gensler的声明,预计明年1月审查力度将会减弱。 主要见解: ETH未平仓合约的表现超过BTC:永续合约数据显示,BTC未平仓合约逐渐减少,而ETH合约增加。尽管本周整体市场较为低迷,但在过去6个月的时间框架内,ETH在每日交易量中也占据了更大的份额。这种乐观情绪可能归因于投资者对Gensler在2025年1月20日离职后,SEC主席将更加亲加密的预期。 BTC价格回落:BTC价格从10万美元关口回落,导致ATM波动率期限结构趋于平坦,短期期权跌破60%。这与美国大选以来观察到的模式相符。较低的已实现波动率解释了这一跌幅,而看涨期权和看跌期权的未平仓合约保持不变,本周对短期期权的需求停滞不前。 ETH期权——适度看涨情绪:ETH期权显示出比BTC期权略微更强烈的看涨情绪。市场在大选后高点之后进行了重新校准,但看涨期权在交易量和未平仓合约方面仍然领先。 获取完整报告: 在此处阅读全文。 #Bybit / #TheCryptoArk /#BybitResearch 关于Bybit Bybit是全球交易量第二大的加密货币交易所,服务超过5000万用户。Bybit成立于2018年,提供一个专业的平台,让加密货币投资者和交易者可以找到超快速的匹配引擎、全天候客户服务和多语言社区支持。Bybit是F1一级方程式赛车现任车队和车手冠军——奥拉科尔红牛车队的骄傲合作伙伴。 有关Bybit的更多详情,请访问 媒体查询,请联系: 更多信息,请访问: 最新动态,请关注: | | | | | | | | 照片 – 标识 – 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More